Cargando…
Two year persistent treatment effect in reducing nasal symptoms of cat allergy after 4 doses of Cat-PAD, the first in a new class of synthetic peptide immuno-regulatory epitopes
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716539/ http://dx.doi.org/10.1186/2045-7022-3-S2-O7 |
| _version_ | 1782277546919854080 |
|---|---|
| author | Hafner, Roderick Couroux, Peter Armstrong, Kristen Patel, Deepen Larche, Mark Haumann, Brett |
| author_facet | Hafner, Roderick Couroux, Peter Armstrong, Kristen Patel, Deepen Larche, Mark Haumann, Brett |
| author_sort | Hafner, Roderick |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3716539 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-37165392013-07-22 Two year persistent treatment effect in reducing nasal symptoms of cat allergy after 4 doses of Cat-PAD, the first in a new class of synthetic peptide immuno-regulatory epitopes Hafner, Roderick Couroux, Peter Armstrong, Kristen Patel, Deepen Larche, Mark Haumann, Brett Clin Transl Allergy Oral Presentation BioMed Central 2013-07-16 /pmc/articles/PMC3716539/ http://dx.doi.org/10.1186/2045-7022-3-S2-O7 Text en Copyright © 2013 Hafner et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Oral Presentation Hafner, Roderick Couroux, Peter Armstrong, Kristen Patel, Deepen Larche, Mark Haumann, Brett Two year persistent treatment effect in reducing nasal symptoms of cat allergy after 4 doses of Cat-PAD, the first in a new class of synthetic peptide immuno-regulatory epitopes |
| title | Two year persistent treatment effect in reducing nasal symptoms of cat allergy after 4 doses of Cat-PAD, the first in a new class of synthetic peptide immuno-regulatory epitopes |
| title_full | Two year persistent treatment effect in reducing nasal symptoms of cat allergy after 4 doses of Cat-PAD, the first in a new class of synthetic peptide immuno-regulatory epitopes |
| title_fullStr | Two year persistent treatment effect in reducing nasal symptoms of cat allergy after 4 doses of Cat-PAD, the first in a new class of synthetic peptide immuno-regulatory epitopes |
| title_full_unstemmed | Two year persistent treatment effect in reducing nasal symptoms of cat allergy after 4 doses of Cat-PAD, the first in a new class of synthetic peptide immuno-regulatory epitopes |
| title_short | Two year persistent treatment effect in reducing nasal symptoms of cat allergy after 4 doses of Cat-PAD, the first in a new class of synthetic peptide immuno-regulatory epitopes |
| title_sort | two year persistent treatment effect in reducing nasal symptoms of cat allergy after 4 doses of cat-pad, the first in a new class of synthetic peptide immuno-regulatory epitopes |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716539/ http://dx.doi.org/10.1186/2045-7022-3-S2-O7 |
| work_keys_str_mv | AT hafnerroderick twoyearpersistenttreatmenteffectinreducingnasalsymptomsofcatallergyafter4dosesofcatpadthefirstinanewclassofsyntheticpeptideimmunoregulatoryepitopes AT courouxpeter twoyearpersistenttreatmenteffectinreducingnasalsymptomsofcatallergyafter4dosesofcatpadthefirstinanewclassofsyntheticpeptideimmunoregulatoryepitopes AT armstrongkristen twoyearpersistenttreatmenteffectinreducingnasalsymptomsofcatallergyafter4dosesofcatpadthefirstinanewclassofsyntheticpeptideimmunoregulatoryepitopes AT pateldeepen twoyearpersistenttreatmenteffectinreducingnasalsymptomsofcatallergyafter4dosesofcatpadthefirstinanewclassofsyntheticpeptideimmunoregulatoryepitopes AT larchemark twoyearpersistenttreatmenteffectinreducingnasalsymptomsofcatallergyafter4dosesofcatpadthefirstinanewclassofsyntheticpeptideimmunoregulatoryepitopes AT haumannbrett twoyearpersistenttreatmenteffectinreducingnasalsymptomsofcatallergyafter4dosesofcatpadthefirstinanewclassofsyntheticpeptideimmunoregulatoryepitopes |